SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2013. The put-call ratio across all filers is 0.12 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $19,000 | -29.6% | 77,700 | 0.0% | 0.00% | – |
| Q4 2015 | $27,000 | -80.3% | 77,700 | -1.2% | 0.00% | – |
| Q3 2015 | $137,000 | -21.7% | 78,624 | 0.0% | 0.00% | – |
| Q2 2015 | $175,000 | +136.5% | 78,624 | +105.2% | 0.00% | – |
| Q1 2015 | $74,000 | 0.0% | 38,324 | +37.7% | 0.00% | – |
| Q4 2014 | $74,000 | -36.2% | 27,824 | -27.8% | 0.00% | – |
| Q3 2014 | $116,000 | +18.4% | 38,524 | +61.0% | 0.00% | – |
| Q2 2014 | $98,000 | -50.0% | 23,924 | -47.4% | 0.00% | – |
| Q1 2014 | $196,000 | -22.8% | 45,445 | -6.3% | 0.00% | – |
| Q4 2013 | $254,000 | -36.8% | 48,524 | -23.8% | 0.00% | – |
| Q3 2013 | $402,000 | -33.8% | 63,667 | -47.7% | 0.00% | -100.0% |
| Q2 2013 | $607,000 | – | 121,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 23,634,349 | $149,133,000 | 99.87% |
| Perceptive Advisors | 4,762,472 | $30,052,000 | 1.24% |
| QVT Financial LP | 1,750,285 | $11,044,000 | 0.75% |
| NBW CAPITAL LLC | 404,721 | $2,554,000 | 0.45% |
| Tekla Capital Management LLC | 489,750 | $3,090,000 | 0.34% |
| MILES CAPITAL, INC. | 57,904 | $365,000 | 0.21% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 435,200 | $2,746,000 | 0.16% |
| Old West Investment Management, LLC | 49,136 | $310,000 | 0.15% |
| Integre Asset Management, LLC | 84,420 | $533,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 250,952 | $1,584,000 | 0.10% |